246 related articles for article (PubMed ID: 37270520)
1. Structural modification of resveratrol analogue exhibits anticancer activity against lung cancer stem cells via suppression of Akt signaling pathway.
Thongsom S; Racha S; Petsri K; Ei ZZ; Visuttijai K; Moriue S; Yokoya M; Chanvorachote P
BMC Complement Med Ther; 2023 Jun; 23(1):183. PubMed ID: 37270520
[TBL] [Abstract][Full Text] [Related]
2.
Thongsom S; Racha S; Ei ZZ; Petsri K; Aksorn N; Chamni S; Panpuang V; Zou H; Chanvorachote P
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674871
[TBL] [Abstract][Full Text] [Related]
3. Novel Synthetic Derivative of Renieramycin T Right-Half Analog Induces Apoptosis and Inhibits Cancer Stem Cells via Targeting the Akt Signal in Lung Cancer Cells.
Petsri K; Yokoya M; Racha S; Thongsom S; Thepthanee C; Innets B; Ei ZZ; Hotta D; Zou H; Chanvorachote P
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982418
[TBL] [Abstract][Full Text] [Related]
4. Akt/mTOR Targeting Activity of Resveratrol Derivatives in Non-Small Lung Cancer.
Innets B; Thongsom S; Petsri K; Racha S; Yokoya M; Moriue S; Chaotham C; Chanvorachote P
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500361
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits viability and induces apoptosis in the small‑cell lung cancer H446 cell line via the PI3K/Akt/c‑Myc pathway.
Li W; Li C; Ma L; Jin F
Oncol Rep; 2020 Nov; 44(5):1821-1830. PubMed ID: 32901891
[TBL] [Abstract][Full Text] [Related]
6. 5-
Suksamai D; Racha S; Sriratanasak N; Chaotham C; Aphicho K; Lin ACK; Chansriniyom C; Suwanborirux K; Chamni S; Chanvorachote P
Mar Drugs; 2022 Mar; 20(4):. PubMed ID: 35447911
[TBL] [Abstract][Full Text] [Related]
7. Luteoloside induces G
Zhou M; Shen S; Zhao X; Gong X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
[TBL] [Abstract][Full Text] [Related]
8. Alantolactone enhances gemcitabine sensitivity of lung cancer cells through the reactive oxygen species-mediated endoplasmic reticulum stress and Akt/GSK3β pathway.
Wang J; Zhang Y; Liu X; Wang J; Li B; Liu Y; Wang J
Int J Mol Med; 2019 Sep; 44(3):1026-1038. PubMed ID: 31524219
[TBL] [Abstract][Full Text] [Related]
9. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition.
Sanookpan K; Nonpanya N; Sritularak B; Chanvorachote P
Molecules; 2021 Jan; 26(3):. PubMed ID: 33530617
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Effect of Polyphyllin I in Suppressing Stem Cell-Like Properties of Hepatocellular Carcinoma via the AKT/GSK-3
Liao M; Du H; Wang B; Huang J; Huang D; Tong G
Oxid Med Cell Longev; 2022; 2022():4031008. PubMed ID: 36317061
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
[TBL] [Abstract][Full Text] [Related]
12. Cancer Stem Cell-Suppressing Activity of Chrysotoxine, a Bibenzyl from
Bhummaphan N; Pongrakhananon V; Sritularak B; Chanvorachote P
J Pharmacol Exp Ther; 2018 Feb; 364(2):332-346. PubMed ID: 29217540
[TBL] [Abstract][Full Text] [Related]
13. [TNF-α activates PI3K/AKT pathway to promote proliferation of SW620
Dai L; Zhao X; Ma L; Li X; Zuo D; Li Y; Wei B; Sui Y; Xu F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):33-41. PubMed ID: 32314722
[TBL] [Abstract][Full Text] [Related]
14. Hydroquinone 5-
Hongwiangchan N; Sriratanasak N; Wichadakul D; Aksorn N; Chamni S; Chanvorachote P
Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832894
[TBL] [Abstract][Full Text] [Related]
15. Simplified Synthesis of Renieramycin T Derivatives to Target Cancer Stem Cells via β-Catenin Proteasomal Degradation in Human Lung Cancer.
Ei ZZ; Racha S; Yokoya M; Hotta D; Zou H; Chanvorachote P
Mar Drugs; 2023 Nov; 21(12):. PubMed ID: 38132948
[TBL] [Abstract][Full Text] [Related]
16. Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer.
Rajagopalan P; Alahmari KA; Elbessoumy AA; Balasubramaniam M; Suresh R; Shariff ME; Chandramoorthy HC
Cancer Chemother Pharmacol; 2016 Feb; 77(2):393-404. PubMed ID: 26781309
[TBL] [Abstract][Full Text] [Related]
17. Isobavachalcone isolated from
Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
[No Abstract] [Full Text] [Related]
18. Tanshinone IIA derivatives induced S-phase arrest through stabilizing c-myc G-quadruplex DNA to regulate ROS-mediated PI3K/Akt/mTOR pathway.
Wang T; Zou J; Wu Q; Wang R; Yuan CL; Shu J; Zhai BB; Huang XT; Liu NZ; Hua FY; Wang XC; Mei WJ
Eur J Pharmacol; 2021 Dec; 912():174586. PubMed ID: 34710368
[TBL] [Abstract][Full Text] [Related]
19. Pongol Methyl Ether Inhibits Akt and Suppresses Cancer Stem Cell Phenotypes in Lung Cancer Cells.
Silapech A; Racha S; Aksorn N; Lafauy P; Tungsukruthai S; Vinayanuwattikun C; Sritularak B; Chanvorachote P
Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832867
[TBL] [Abstract][Full Text] [Related]
20. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
